GPC3 and neoplasm: To further evaluate the anti-tumor effects of GPC3-CAR-T cells in vivo, we established a cell line-derived xenograft (CDX) model by subcutaneously injecting GFP/Luc+ Huh7 into immunodeficient NCG mice.